13087 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Levine
    Levine
  4. Zelenetz
    Zelenetz
  5. Horwitz
    Horwitz
  6. Abdel-Wahab
    Abdel-Wahab
  7. Scheinberg
    Scheinberg
  8. Jakubowski
    Jakubowski
  9. Landau
    Landau
  10. Shah
    Shah

Groups

  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)
  7. Lymphoma (2639)
  8. Sloan Kettering Institute Faculty (2602)
  9. Executive Committee, Center for Hematologic Malignancies (2358)
  10. Survivorship Research (2328)
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic transplant in patients ≥60 years of age with first relapsed or refractory acute myeloid leukemia after treatment with vosaroxin or placebo plus cytarabine: Results from VALOR
    Meeting Abstract

    Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Erba, H. P.; Pigneux, A.; Horst, H. A.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Long-term outcome of 490 patients with early-stage extra-nodal marginal zone lymphoma
    Meeting Abstract

    Yahalom, J.; Teckie, S.; Qi, S.; Hsu, M.; Lovie, S.; Chelius, M.; Noy, A.; Portlock, C.
    Haematologica (2015)

    Fulltext@MSK | Save
  • NEOD001 demonstrates cardiac and renal biomarker responses in a phase 1/2 study in patients with AL amyloidosis and persistent organ dysfunction
    Meeting Abstract

    Liedtke, M.; Landau, H.; Comenzo, R.; Seldin, D.; Weiss, B.; ZonDer, J.; Walling, J.; Kinney, G.; Koller, M.; Gertz, M. A.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Single-cell analysis of myelodysplastic sydrome stem cells during therapy and disease progression
    Meeting Abstract

    Park, C. Y.; Vijay, P.; Chung, S. S.; Stern, D.; Klimek, V.; Mason, C. E.
    Experimental Hematology (2015)

    Fulltext@MSK | Save
  • Pneumonitis with anti-PD-1/PD-L1 therapy
    Meeting Abstract

    Naidoo, J.; Cunningham, J.; Woo, K. M.; Hellmann, M. D.; Postow, M. A.; Drilon, A. E.; Chaft, J. E.; Lesokhin, A. M.; Segal, N. H.; Callahan, M. K.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • A novel high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory acute myeloid leukemia (AML): Proof of concept and clinical implementation of precision medicine
    Meeting Abstract

    Shum, D.; Santos, R.; Heaney, M.; Brentjens, R.; Maslak, P.; Rosenblat, T.; Jurcic, J.; Djaballah, H.; Frattini, M. G.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Use of a high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory AML: Proof of concept and clinical implementation of precision medicine
    Meeting Abstract

    Shum, D.; Heaney, M.; Brentjens, R.; Maslak, P.; Jurcic, J.; Djaballah, H.; Frattini, M. G.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Role of JAK-STAT pathway activation in MPN pathogenesis and therapeutic response
    Meeting Abstract

    Meyer, S.; Kleppe, M.; Bhagwat, N.; Koppikar, P.; Kwak, M.; Radimerski, T.; Fan, R.; Levine, R. L.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • SRSF2 mutations impair hematopoietic differentiation by altering exonic splicing enhancer preference
    Meeting Abstract

    Kim, E.; Ilagan, J. O.; Lee, S.; Ramakrishnan, A.; Chung, Y. R.; Micol, J. B.; Murphy, M. E.; Kim, M. K.; Zebari, A. S.; Buonamici, S.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save